S. R. Smith, N. J. Weissman, C. M. Anderson u. a.: Multicenter, placebo-controlled trial of lorcaserin for weight management. In: N. Engl. J. Med.Band363, Nr.3, Juli 2010, S.245–256, doi:10.1056/NEJMoa0909809, PMID 20647200.
W. J. Thomsen, A. J. Grottick, F. Menzaghi u. a.: Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. In: J. Pharmacol. Exp. Ther.Band325, Nr.2, Mai 2008, S.577–587, doi:10.1124/jpet.107.133348, PMID 18252809.
B. M. Smith, J. M. Smith, J. H. Tsai u. a.: Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity. In: Bioorg. Med. Chem. Lett. Band15, Nr.5, März 2005, S.1467–1470, doi:10.1016/j.bmcl.2004.12.080, PMID 15713408.
S. R. Smith, N. J. Weissman, C. M. Anderson u. a.: Multicenter, placebo-controlled trial of lorcaserin for weight management. In: N. Engl. J. Med.Band363, Nr.3, Juli 2010, S.245–256, doi:10.1056/NEJMoa0909809, PMID 20647200.
W. J. Thomsen, A. J. Grottick, F. Menzaghi u. a.: Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. In: J. Pharmacol. Exp. Ther.Band325, Nr.2, Mai 2008, S.577–587, doi:10.1124/jpet.107.133348, PMID 18252809.
B. M. Smith, J. M. Smith, J. H. Tsai u. a.: Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity. In: Bioorg. Med. Chem. Lett. Band15, Nr.5, März 2005, S.1467–1470, doi:10.1016/j.bmcl.2004.12.080, PMID 15713408.
A. A. Bajrai, E. Ezzeldin, K. A. Al-Rashood, M. Raish, M. Iqbal: A Validated UPLC-MS-MS Assay for the Rapid Determination of Lorcaserin in Plasma and Brain Tissue Samples. In: J Anal Toxicol. Band 40, Nr. 2, Mar 2016, S. 133–139. PMID 26567546
R. Hachem, M. Malet-Martino, V. Gilard: First identification and quantification of lorcaserin in an herbal slimming dietary supplement. In: J Pharm Biomed Anal. Band 98, Sep 2014, S. 94–99. PMID 24905289